Safety and Immunogenicity of Haemophilus influenzae-Tetanus Toxoid Conjugate Vaccine Given Separately or in Combination with a Three-Component Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids and Inactivated Poliovirus Vaccine for the First Four Doses
Scott A.Halperin, J.K.,B.L.,E.M.andP.W.
Clinical Infectious Diseases 28(5): 995-1001
1999
ISSN/ISBN: 1058-4838
DOI: 10.2307/4481797
Accession: 068387891
PDF emailed within 0-6 h: $19.90
Related References
Halperin, S.A.; King, J.; Law, B.; Mills, E.; Willems, P. 1999: Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 28(5): 995-1001Pichichero, M.E.; Bernstein, H.; Blatter, M.M.; Schuerman, L.; Cheuvart, B.; Holmes, S.J. 2007: Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine Journal of Pediatrics 151(1): 43-49; 49.E1-2
Pichichero, M.E.; Bernstein, H.; Blatter, M.M.; Schuerman, L.; Cheuvart, B.; Holmes, S.J.; S I, S. I. 2007: Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus Influenzae type b conjugate vaccine The Journal of Pediatrics 151(1): 43-49
Gold, R.; Scheifele, D.; Barreto, L.; Wiltsey, S.; Bjornson, G.; Meekison, W.; Guasparini, R.; Medd, L. 1994: Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age Pediatric Infectious Disease Journal 13(5): 348-355
Lee, C.Y.; Thipphawong, J.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Lin, W.; Debois, H.; Harrison, D.; Xie, F.; Barreto, L. 1999: An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants Pediatrics 103(1): 25-30
Tejedor, J.C.; Moro, M.; Ruiz-Contreras, J.ús.; Castro, J.; Gómez-Campderá, J.é A.; Navarro, M.ía.L.; Merino, J.é M.; Martín-Ancel, A.; Roca, J.; García-Del-Rí, M.; Jurado, A.; Díez-Delgado, F.J.; Omeñaca, F.él.; García-Sicilia, J.é; Boceta, R.; García-Corbeira, P.; Collard, A.; Boutriau, D.; Schuerman, L.; Jacquet, J.-M. 2007: Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months Pediatric Infectious Disease Journal 26(1): 1-7
Dagan, R.; Igbaria, K.; Piglansky, L.; Melamed, R.; Willems, P.; Grossi, A.; Kaufhold, A. 1997: Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine Pediatric Infectious Disease Journal 16(12): 1113-1121
Gimenez-Sanchez, F.; Kieninger, D.M.; Kueper, K.; Martinon-Torres, F.; Bernaola, E.; Diez-Domingo, J.; Steul, K.; Juergens, C.; Gurtman, A.; Giardina, P.; Liang, J.Z.; Gruber, W.C.; Emini, E.A.; Scott, D.A.; Amor-Peix, Mía.; Antelo, J.; Arimany, J.Lluis.; Baca-Cots, M.; Baldo, J.; Sanz, A.Ballester.; Blesa, L.; Carmen-Peidró, M.; Carmona, A.; Casares, J.; Cubells, J.Maria.; Rubio, A.Delgado.; Diez-Delgado, J.; Escribano, E.; Fernändez-Cuesta, M.Angel.; Fernandez-Prieto, Rón.; Garcés, M.; García-Bernal, M.; Hernandez-Merino, A.; Infante-Marquez, P.; Jubert, A.; Martinez-Po 2011: Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine Vaccine 29(35): 6042-6048
Dutta, A.K.; Verghese, V.P.; Pemde, H.K.; Mathew, L.G.; Ortiz, E. 2009: Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine Indian Pediatrics 46(11): 975-982
Tejedor, J.C.; Moro, M.; Ruiz-Contreras, J.; Castro, J.; Gómez-Campderá, J.A.; Navarro, M.Luisa.; Merino, J.Manuel.; Martín-Ancel, A.; Roca, J.; García-del-Río, M.; Jurado, A.; Díez-Delgado, F.Javier.; Omeñaca, F.; García-Sicilia, J.; Boceta, R.; García-Corbeira, P.; Jacquet, J-Marie.; Collard, A.; Schuerman, L. 2006: Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine Pediatric Infectious Disease Journal 25(8): 713-720
Vesikari, T.; Silfverdal, S.A.; Boisnard, F.; Thomas, S.ép.; Mwawasi, G.; Reynolds, D. 2013: Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age Clinical and Vaccine Immunology: Cvi 20(10): 1647-1653
Partridge, S.; Alvey, J.; Bernstein, H.; Blatter, M.; Bottenfield, G.; Guerrero, J.; Senders, S.D.; Schuerman, L.; Cheuvart, B.; Holmes, S.J. 2007: Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine Vaccine 25(10): 1806-1813
Zepp, F.; Knuf, M.; Heininger, U.; Jahn, K.; Collard, A.; Habermehl, P.; Schuerman, L.; Sänger, R. 2004: Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants Vaccine 22(17-18): 2226-2233
Schmitt, H.J.; Zepp, F.; Müschenborn, S.; Sümenicht, G.; Schuind, A.; Beutel, K.; Knuf, M.; Bock, H.L.; Bogaerts, H.; Clemens, R. 1998: Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations European Journal of Pediatrics 157(3): 208-214
Greenberg, D.P.; Wong, V.K.; Partridge, S.; Chang, S.J.; Jing, J.; Howe, B.J.; Ward, J.I. 2000: Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine Pediatric Infectious Disease Journal 19(12): 1135-1140
Moss, S.J.; Fenton, A.C.; Toomey, J.; Grainger, A.; Borrow, R.; Balmer, P.; Smith, J.; Gennery, A.R. 2010: Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type B vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age Clinical and Vaccine Immunology: Cvi 17(3): 311-316
Heininger, U.; Sänger, R.; Jacquet, J.-M.; Schuerman, L. 2007: Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses Vaccine 25(6): 1055-1063
Bernstein, H.; Garrison, K.; Kurt Jones, E.; Marchant, C. 1998: Immunogenicity of diphtheria-tetanus-acellular pertussis vaccine combined with Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in 2, 4, and 6 month old infants Pediatric Research 43(4 Part 2): 141A
Daum, R.S.; Zenko, C.E.; Given, G.Z.; Ballanco, G.A.; Parikh, H.; Vidor, E.; Liu, X. 2000: Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine in the same syringe and inactivated polio vaccine Pediatric Infectious Disease Journal 19(8): 710-717
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322